Androgenic Alopecia Therapeutics Market Analysis and Forecast by 2031

MARKET INTRODUCTION

Androgenic alopecia is a genetic condition, which results into hair loss among both men and women. In the case of men, the hairline recedes, gradually leading to disappearance of hair from the crown and frontal scalp, whereas among women, a common thinning over the entire scalp with most extensive hair loss at the crown is witnessed. Some medical conditions leading to the occurrence of androgenic alopecia includes, enlargement or tumor in the prostate among men, coronary heart disease, diabetes and high blood pressure. Among women, the occurrence of androgenic alopecia is associated with polycystic ovary syndrome (PCOS).

MARKET DYNAMICS

The androgenic alopecia therapeutics market is anticipated to grow in the forecast, owing to rise in the cases of androgenic alopecia across the globe, coupled with change in lifestyle leading to baldness. Also, increased R&D expenditure for the development of innovative products are expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Androgenic Alopecia Therapeutics Market Analysis to 2031" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of androgenic alopecia therapeutics market with detailed market segmentation by therapy type, gender, sales channel, end user and geography. The androgenic alopecia therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading androgenic alopecia therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The androgenic alopecia therapeutics market is segmented based on therapy type, gender, sales channel, and end user. Based on therapy type the market is segmented as, medicines, surgery and other therapies. Based on gender the market is categorized as, female and male. Based on sales channel, the market is categorized as, over-the-counter (OTC) and prescription. Similarly, based on end user, the androgenic alopecia therapeutics market is classified as, hospitals, dermatology clinics and home care settings.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the androgenic alopecia therapeutics market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The androgenic alopecia therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting androgenic alopecia therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the androgenic alopecia therapeutics market in these regions.

MARKET PLAYERS

The report covers key developments in the androgenic alopecia therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from androgenic alopecia therapeutics market are anticipated to have lucrative growth opportunities in the future with the rising demand for androgenic alopecia therapeutics market in the global market. Below mentioned is the list of few companies engaged in the androgenic alopecia therapeutics market.

The report also includes the profiles of key androgenic alopecia therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Almirall, S.A.
- BiologicsMD, Inc.
- Brickell Biotech, Inc.
- Cipla Inc.
- Concert Pharmaceuticals
- Dr. Reddy's Laboratories Ltd.
- HairClone Limited
- Merck & Co., Inc.
- RepliCel Life Sciences
- RiverTown Therapeutics Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Androgenic Alopecia Therapeutics Report Scope